Institute of Medical Epidemiology, Biometry and Epidemiology, University Hospital of Halle, Halle, Germany, email@example.com (Stang, Schmidt-Pokrzywniak)
Institute of Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany (Jöckel)
To the Editor:
We read with interest the publication by Lönn et al1 who studied the association between time since first regular mobile phone use and acoustic neuroma. They found an increased risk of acoustic neuroma among subjects with at least 10 years since first regular use of analog mobile phones (odds ratio [OR] = 1.8; 95% confidence interval [CI] = 0.8–4.3).
If one accepts that acoustic neuroma is a slow-growing tumor initiated years before clinical diagnosis,2 the only etiologically valid analysis would be among subjects who were exposed to mobile phones at least several years before the reference date. For subjects with few years since first exposure, the exposure cannot be causally involved in the etiology of acoustic neuroma.
Assuming that analog radiofrequency devices increase the risk of cancer, some epidemiologic findings would fit together. Auvinen et al3 undertook a register-based case-control study on cellular phone and brain tumors in Finland. This study did not have any nonresponse bias or differential exposure misclassification by study design. They found an OR of 2.1 (95% CI = 1.3–3.4) for glioma among subjects ever exposed to analog mobile phones. This ever/never analysis can only suffer from nondifferential exposure misclassification by definition and therefore can be considered as a conservative effect estimate. The same analysis for digital mobile phone use revealed an OR of 1.0 (0.5–2.0).
In our case-control study on uveal melanoma,4 we found an increased risk among subjects exposed to radio sets that use analog techniques. We therefore started a new case-control study5 on radiofrequency radiation and uveal melanoma risk, for which we expect results in 2005.
Muscat et al6 found an increased risk of acoustic neuroma among subjects who used mobile phones for at least 3 to 6 years (the longest interval in their study) in a case-control study in the United States with 88% of all mobile phone users using analog phones.
Furthermore, the recent case-control study of Hardell et al,7 which has some methodologic limitation, showed increased risks of brain tumors among subjects exposed to analog mobile phones with a latency of more than 10 years.
The study by Lönn et al1 makes it more difficult to ignore the accumulating, although vague, evidence that may hint to an etiologic role of analog mobile phones in the causation of acoustic neuroma and other tumors.
Institute of Medical Epidemiology, Biometry and Epidemiology, University Hospital of Halle, Halle, Germany, firstname.lastname@example.org
Institute of Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
1. Lönn S, Ahlbom A, Hall P, et al. Mobile phone use and the risk of acoustic neuroma. Epidemiology
2. van Leeuwen JP, Harhangi BS, Thewissen NP, et al. Delays in the diagnosis of acoustic neuromas. Am J Otol
3. Auvinen A, Hietanen M, Luukkonen R, et al. Brain tumors and salivary gland cancers among cellular telefone users. Epidemiology
4. Stang A, Anastassiou G, Ahrens W, et al. The possible role of radio-frequency radiation in the development of uveal melanoma. Epidemiology
5. Schmidt-Pokrzywniak A, Jöckel KH, Bornfeld N, et al. Case–control study on uveal melanoma (RIFA): rational and design. BMC Ophthalmology
6. Muscat JE, Malkin MG, Shore RE, et al. Handheld cellular telephones and risk of acoustic neuroma. Neurology
7. Hardell L, Hallquist A, Hansson Mild K, et al. Cellular and cordless telephones and the risk for brain tumors. Eur J Cancer Prev